MemoDefend Reviews – Negative Side Effects or Real Benefits?
09 avr. 2021 19h47 HE
|
Marketing By Kevin
Chicago, IL, April 09, 2021 (GLOBE NEWSWIRE) -- Memo Defend is a dietary supplement that claims to help older adults recover from total memory loss using a variety of high powered natural...
TINA.org Files FTC Complaint Against “Brain Training” Company Neurocore
12 nov. 2019 13h31 HE
|
truthinadvertising.org
MADISON, CONN., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Ad watchdog truthinadvertising.org (TINA.org) has filed a complaint with the Federal Trade Commission (FTC) against Neurocore, a “brain training"...
Cognition Therapeutics Initiates NIA-Funded SPARC Study of Elayta™ to Assess Changes in Synaptic Density and Cognitive Performance in Alzheimer's Disease
18 juin 2018 08h03 HE
|
Cognition Therapeutics, Inc.
Pittsburgh, June 18, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on synaptic health and restoration in neurocognitive disorders, today...
Kmart Pharmacy Joins Alzheimer’s Foundation of America to Raise Awareness and Offer Free Memory Screenings Nationwide this May
26 avr. 2018 09h26 HE
|
Alzheimer's Foundation of America
NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) and Kmart Pharmacy are continuing their strong collaboration in 2018, as Kmart will conduct free memory...
Alzheimer’s Virtual Reality Sensory Experience Featured at Upcoming ASA Workshop
23 mars 2018 09h31 HE
|
Alzheimer's Foundation of America
SAN FRANCISCO, March 23, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA)—in collaboration with Greener Media—is hosting a workshop titled, "What Would You Do: A Sensory...
Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at the Annual ASENT Meeting
06 mars 2018 14h04 HE
|
Cognition Therapeutics, Inc.
Pittsburgh, March 06, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...
Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum
04 janv. 2018 08h05 HE
|
Cognition Therapeutics, Inc.
Pittsburgh, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...
Cognition Therapeutics CEO Kenneth I. Moch to Present at the Stifel 2017 Healthcare Conference
08 nov. 2017 08h12 HE
|
Cognition Therapeutics, Inc.
Pittsburgh, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...
Cognition Therapeutics CEO Kenneth I. Moch to Present at Canaccord Genuity Annual Growth Conference
31 juil. 2017 08h30 HE
|
Cognition Therapeutics, Inc.
Pittsburgh, July 31, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...
Cognition Therapeutics Reports Drug-Drug Interaction Results for CT1812, a Disease-Modifying Alzheimer’s Disease Candidate
19 juil. 2017 04h35 HE
|
Cognition Therapeutics, Inc.
PITTSBURGH, July 19, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative small molecule therapeutics for the...